ProPhase Labs Inc (PRPH)
5.42
+0.11
(+2.07%)
USD |
NASDAQ |
May 03, 16:00
5.47
+0.05
(+0.92%)
After-Hours: 20:00
ProPhase Labs Cash from Financing (Quarterly): 2.924M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.924M |
| September 30, 2023 | 1.20M |
| June 30, 2023 | -0.047M |
| March 31, 2023 | 1.68M |
| December 31, 2022 | -9.498M |
| September 30, 2022 | -3.122M |
| June 30, 2022 | -6.181M |
| March 31, 2022 | -7.222M |
| December 31, 2021 | -0.962M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | -4.546M |
| March 31, 2021 | 40.64M |
| December 31, 2020 | 0.066M |
| September 30, 2020 | 9.924M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | -2.893M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | -2.929M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | -11.36M |
| March 31, 2018 | 0.00 |
| December 31, 2017 | -3.825M |
| Date | Value |
|---|---|
| September 30, 2017 | -9.192M |
| June 30, 2017 | -1.756M |
| March 31, 2017 | -1.431M |
| December 31, 2016 | -0.10M |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 1.38M |
| September 30, 2015 | 1.04M |
| June 30, 2015 | 0.524M |
| March 31, 2015 | |
| December 31, 2014 | -0.099M |
| September 30, 2014 | 0.083M |
| June 30, 2014 | 3.879M |
| March 31, 2014 | 0.947M |
| December 31, 2013 | 0.149M |
| September 30, 2013 | 0.027M |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.195M |
| December 31, 2012 | 1.07M |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
| September 30, 2011 | -0.449M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-9.498M
Minimum
Dec 2022
40.64M
Maximum
Mar 2021
1.156M
Average
--
Median
Jun 2019
Cash from Financing (Quarterly) Benchmarks
| Fonar Corp | -2.406M |
| XWELL Inc | 0.00 |
| Applied DNA Sciences Inc | -0.0351M |
| Veracyte Inc | 0.645M |
| OncoCyte Corp | -0.03M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.213M |
| Cash from Investing (Quarterly) | -1.264M |
| Free Cash Flow | -14.50M |
| Free Cash Flow Per Share (Quarterly) | -0.0843 |
| Free Cash Flow to Equity (Quarterly) | -4.482M |
| Free Cash Flow to Firm (Quarterly) | -1.182M |
| Free Cash Flow Yield | -15.26% |